Further coverage from the 9th Annual Value Investing Congress continues now. Michael Castor, Sio Capital: is the next speaker today. The topic of the presentation is the ‘Accounting Game’.

Michael Castor

Prior to entering finance, Michael Castor, MD, spent three years in clinical medicine, completing his surgery internship at Indiana University Medical Center and then two years of residency at Columbia. In 2000, he joined J.P. Morgan, where he focused on biotech and healthcare IPOs. In 2001, he joined Stanford Bernstein where he evaluated long and short investments for several of Bernstein’s funds and ultimately served as the healthcare sector leader. Michael is the PM of a healthcare-focused hedge fund, Sio Capital Management, LLC, which Michael founded in 2006.

Six options to find content: Value Investing Congress

Come back to find the latest. Other (and easier options include), You can (and should) sign up for our newsletter. Or  follow us on  Google+LinkedinTwitterFacebook,  RSS.

Michael Castor live coverage

Runs a Global L/S Healthcare Hedge Fund

Stretched Valuations: MWI Vetinary (NYSE:MWIV) , SRCL

Attractive Valuations: Cardinal Health (NYSE:CAH) , SEM

Hidden Gem: Aratana (NYSE: PETX)

Focus of presentation on accounting

Genomma Lab Internacional SAB De CV (OTCMKTS:GNMLF) –

Talking about accounts receivable, and now other assets growing rapidly….investors are concerned. Genomma is a mexican over the counter product company.

His thesis is that they are missing 4.9B pesos on the balance sheet.  Essentially where did all the cash go…. – Got asked about Herbalife Ltd. (NYSE:HLF) — no position, but thinks the business model is broken.

ValueWalk readers can get a 53% discount on the Value Investing Congress in Vegas (April 3rd and 4th), just use this link to register.

Use code ‘WALK’ to save an extra $100.